Identification of Druggable Targets for Acinetobacter baumannii Via Subtractive Genomics and Plausible Inhibitors for MurA and MurB
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Druggable Targets for Acinetobacter baumannii Via Subtractive Genomics and Plausible Inhibitors for MurA and MurB
Authors
Keywords
Subtractive genomics, <em class=EmphasisTypeItalic >Acinetobacter baumannii</em>, Peptidoglycan, MurA, MurB, Homology modeling, Molecular docking, Molecular dynamics
Journal
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
Volume 171, Issue 2, Pages 417-436
Publisher
Springer Nature
Online
2013-07-11
DOI
10.1007/s12010-013-0372-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Subtractive Genomics Approach to Identify Putative Drug Targets and Identification of Drug-like Molecules for Beta Subunit of DNA Polymerase III in Streptococcus Species
- (2012) John J. Georrge et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Reorganizing the protein space at the Universal Protein Resource (UniProt)
- (2011) NUCLEIC ACIDS RESEARCH
- Bacterial cell wall assembly: still an attractive antibacterial target
- (2011) Timothy D.H. Bugg et al. TRENDS IN BIOTECHNOLOGY
- Are we closing in on an "elusive enemy"? The current status of our battle withAcinetobacter baumannii
- (2011) Federico Perez et al. Virulence
- The Fungal Product Terreic Acid Is a Covalent Inhibitor of the Bacterial Cell Wall Biosynthetic Enzyme UDP-N-Acetylglucosamine 1-Carboxyvinyltransferase (MurA),
- (2010) Huijong Han et al. BIOCHEMISTRY
- PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes
- (2010) Nancy Y. Yu et al. BIOINFORMATICS
- Structure–activity relationships of tulipalines, tuliposides, and related compounds as inhibitors of MurA
- (2010) Thomas Mendgen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Virtual Screening of potential drug-like inhibitors against Lysine/DAP pathway of Mycobacterium tuberculosis
- (2010) Aarti Garg et al. BMC BIOINFORMATICS
- KiDoQ: using docking based energy scores to develop ligand based model for predicting antibacterials
- (2010) Aarti Garg et al. BMC BIOINFORMATICS
- Peptidoglycan biosynthesis machinery: A rich source of drug targets
- (2010) Ankur Gautam et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- In silico subtractive genomics for target identification in human bacterial pathogens
- (2010) Debmalya Barh et al. DRUG DEVELOPMENT RESEARCH
- Identification of hotspot regions of MurB oxidoreductase enzyme using homology modeling, molecular dynamics and molecular docking techniques
- (2010) Vivek Kumar et al. JOURNAL OF MOLECULAR MODELING
- In silico analysis of antibody triggering biofilm associated protein in Acinetobacter baumannii
- (2010) Mohammad Reza Rahbar et al. JOURNAL OF THEORETICAL BIOLOGY
- Evidence of Kinetic Control of Ligand Binding and Staged Product Release in MurA (Enolpyruvyl UDP-GlcNAc Synthase)-Catalyzed Reactions,
- (2009) Sean G. Jackson et al. BIOCHEMISTRY
- An oldie but a goodie – cell wall biosynthesis as antibiotic target pathway
- (2009) Tanja Schneider et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- 2-Aminotetralones: Novel inhibitors of MurA and MurZ
- (2008) Colin J. Dunsmore et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
- (2008) Drosos E Karageorgopoulos et al. LANCET INFECTIOUS DISEASES
- DEG 5.0, a database of essential genes in both prokaryotes and eukaryotes
- (2008) R. Zhang et al. NUCLEIC ACIDS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started